Mate Gergely

Medicine & Life Sciences

1. Vaccine Immunogenicity 100%
2. Extrahepatic Bile Ducts 96%
3. Esophageal Achalasia 90%
4. Cholestasis 80%
5. Renin-Angiotensin System 73%
6. SARS Virus 70%
7. Angiotensin II 69%
8. Manometry 68%
9. Crohn Disease 68%
10. Inflammatory Bowel Diseases 67%
11. Immunosuppression 64%
12. Hyperplasia 63%
13. Ligation 62%
14. Bile Ducts 62%
15. Prospective Studies 54%
16. Chronic Disease 52%
17. Cohort Studies 48%
18. Capsule Endoscopy 48%
19. anti-IgG 44%
20. Vaccination 44%
21. Biosensing Techniques 43%
22. Smartphone 43%
23. Endoscopy 31%
24. Magnetic Resonance Spectroscopy 29%
25. Cell- and Tissue-Based Therapy 28%
26. Ulcerative Colitis 28%
27. Biological Products 28%
28. Losartan 24%
29. Tomography 24%
30. Biomarkers 23%
31. Guidelines 22%
32. Esophagogastric Junction 22%
33. tofacitinib 22%
34. Therapeutics 20%
35. Fibronectins 20%
36. Vaccines 17%
37. Salvage Therapy 16%
38. Biological Therapy 16%
39. Infliximab 16%
40. Extrahepatic Cholestasis 16%
41. Fibrosis 15%
42. Weight Loss 14%
43. Glucocorticoids 14%
44. Antibody Formation 14%
45. Immunohistochemistry 14%
46. Treatment Failure 13%
47. Messenger RNA 13%
48. Cyclosporine 13%
49. In Vitro Techniques 13%
50. Immunosuppressive Agents 13%